Candel Therapeutics (CADL) Projected to Announce Earnings on Thursday
Written by MarketBeat
November 5, 2026
Add As Preferred Source
Share
Share
Share This Article
Link copied to clipboard.
Close
Image from MarketBeat Media, LLC.
Key Points
Candel Therapeutics is expected to report Q3 2026 results before the market opens November 12 , with analysts forecasting a loss of $0.3372 per share. The earnings call is scheduled for November 13 at 9:30 a.m. ET.
The company reported a $0.52-per-share loss in its previous quarter, missing the consensus estimate of a $0.24 loss. Analysts expect losses of $1.29 per share for the current fiscal year and $1.27 for the next.
Analysts’ consensus rating is “Moderate Buy,” with an average price target of $21.43; nine rate the stock a Buy and two a Sell.
Five stocks we like better than Candel Therapeutics .
Candel Therapeutics ( NASDAQ:CADL - Get Free Report ) will likely be issuing its Q3 2026 results before the market opens on Thursday, November 12th. Analysts expect Candel Therapeutics to announce earnings of ($0.3372) per share for the quarter. Interested persons are encouraged to explore the company's upcoming Q3 2026 earnings overview page for th...